E2814 is an investigational anti-tau antibody. It is not approved for dementia and is available only in research settings.
Eisai’s tau programme is listed so the atlas is not amyloid-only. Benefit and safety remain trial questions. A registry listing is not a recommendation to enrol.
Investigational antibody directed at microtubule-binding-region tau. Connects to Tau.
1.E2814 binds Tau.
Same-target crowding
Products and sponsors that share a biology node on this atlas. A crowded target is a duplication signal, not a recommendation.
Tau is the tangle protein. Its spread tracks symptoms more closely than plaques in many studies.
2 products · 2 sponsors
Products on this atlas
Linked trials
Counts are what this atlas records on one target — not a ranking of funders or clinical promise.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"E2814" OR ABSTRACT:"E2814") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about E2814, not a curated reading list.
Shares Tau-directed therapeutics, Tau, Alzheimer’s disease and the tag dementia-atlas.
Shares Tau, Alzheimer’s disease and the tag dementia-atlas.
Shares Eisai, Alzheimer’s disease and the tag dementia-atlas.
Shares Tau, Alzheimer’s disease and the tag dementia-atlas.
Shares Alzheimer’s disease and the tag dementia-atlas.
Shares Alzheimer’s disease and the tag dementia-atlas.
Shares Alzheimer’s disease and the tag dementia-atlas.
Shares Alzheimer’s disease and the tag dementia-atlas.
